동성제약

002210KOSPI

34.0 / 100

Reference Date: 2026-10-23

Financial Score9.5 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 7.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Dongseong Pharmaceutical operates 13 facilities across South Korea, with headquarters in Seoul, and is divided into three business segments: pharmaceuticals, hair dyes, and cosmetics. Key products include Jeongrohwan, Seven Eight, and Lances, with pharmaceuticals and hair dyes produced in-house at the Asan plant, while cosmetics are sold through purchased goods.

Number of Employees

307people

Average Salary

42.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

5.32Industry Average 1.200.0Point

4.4x industry avg (risky)

ROE

-76.44Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

65.78Industry Average 100.005.0Point

Lower than industry avg (good)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼0.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼629.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -32.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (35%)

Current 1,286Won52-week high 1,84652-week low 973

1-month return1.0Point

1m -7.15% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 0Negative 1

Negative소송등의판결ㆍ결정2026-09-30